logo

Zydus Cadila applies for the Emergency Use Authorization (EUA) seeking approval from the Drugs Controller General of India (DCGI) for the launch of their DNA vaccine for 12 years & above. The vaccine has completed the third phase of the trial.

Leave Your Comment

 

 

Top